" class="no-js "lang="en-US"> PathAI - Medtech Alert
Friday, March 01, 2024
PathAI | Pharmtech Focus


About PathAI


PathAI’s mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.

We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ’s Best Places to Work!

Related Story

PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial

March 31 2023

PathAI, a leading provider of AI-powered pathology, today announced its partnership with GSK on HORIZON, […]

PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb

August 26 2022

PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. […]

Roche Announces PathAI Collaboration for Artificial Intelligence-based Digital Pathology Applications for Improved Patient Care

October 15 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with PathAI, […]

PathAI Announces Completion of $165 Million Financing for Advancing Medicine with AI-powered Pathology

May 20 2021

PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today the closing of […]